Kestra Medical Technologies Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG524411052
USD
28.35
1.95 (7.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

120.94 k

Shareholding (Apr 2026)

FII

8.52%

Held by 45 FIIs

DII

35.03%

Held by 41 DIIs

Promoter

61.07%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Net Sales of 16.64%, the company declared Very Positive results in Apr 26

  • NET PROFIT(HY) Higher at USD -72.86 MM
  • NET SALES(Q) Highest at USD 28.64 MM
  • RAW MATERIAL COST(Y) Fallen by -24.19% (YoY)
2

Risky -

3

High Institutional Holdings at 100%

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,136 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.86

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

3.94

Revenue and Profits:
Net Sales:
29 Million
(Quarterly Results - Apr 2026)
Net Profit:
-39 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
34.68%
0%
34.68%
6 Months
3.85%
0%
3.85%
1 Year
95.25%
0%
95.25%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Kestra Medical Technologies Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
180.00%
EBIT Growth (5y)
-17.71%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.94
EV to EBIT
-6.18
EV to EBITDA
-6.55
EV to Capital Employed
22.78
EV to Sales
10.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-368.81%
ROE (Latest)
-50.76%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 32 Schemes (35.03%)

Foreign Institutions

Held by 45 Foreign Institutions (8.52%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2026 is 16.26% vs 8.85% in Jan 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2026 is -13.45% vs -4.27% in Jan 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'26",
        "Jan'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.60",
          "val2": "24.60",
          "chgp": "16.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-37.00",
          "val2": "-32.80",
          "chgp": "-12.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "1.90",
          "chgp": "-5.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.20",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-38.80",
          "val2": "-34.20",
          "chgp": "-13.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,373.80%",
          "val2": "-1,416.00%",
          "chgp": "4.22%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2026 is 59.03% vs 115.11% in Apr 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2026 is -15.64% vs -20.94% in Apr 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'26",
        "Apr'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.10",
          "val2": "59.80",
          "chgp": "59.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-126.00",
          "val2": "-98.40",
          "chgp": "-28.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.50",
          "val2": "7.70",
          "chgp": "-2.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.70",
          "val2": "2.60",
          "chgp": "-203.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-131.60",
          "val2": "-113.80",
          "chgp": "-15.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,416.40%",
          "val2": "-1,778.50%",
          "chgp": "36.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQstock-summary

Apr'26
Jan'26
Change(%)
Net Sales
28.60
24.60
16.26%
Operating Profit (PBDIT) excl Other Income
-37.00
-32.80
-12.80%
Interest
1.80
1.90
-5.26%
Exceptional Items
-0.40
0.20
-300.00%
Consolidate Net Profit
-38.80
-34.20
-13.45%
Operating Profit Margin (Excl OI)
-1,373.80%
-1,416.00%
4.22%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2026 is 16.26% vs 8.85% in Jan 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2026 is -13.45% vs -4.27% in Jan 2026

Annual Results Snapshot (Consolidated) - Apr'26stock-summary

Apr'26
Apr'25
Change(%)
Net Sales
95.10
59.80
59.03%
Operating Profit (PBDIT) excl Other Income
-126.00
-98.40
-28.05%
Interest
7.50
7.70
-2.60%
Exceptional Items
-2.70
2.60
-203.85%
Consolidate Net Profit
-131.60
-113.80
-15.64%
Operating Profit Margin (Excl OI)
-1,416.40%
-1,778.50%
36.21%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Apr 2026 is 59.03% vs 115.11% in Apr 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Apr 2026 is -15.64% vs -20.94% in Apr 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details